iPhone | iPad
Android
Huawei
Many students wade through waist-deep water to head to neighbour's house for online classes
KT APPDOWNLOAD
India's Hetero Labs, Cipla get approval to make Gilead's Covid-19 drug remdesivir
Gilead signed non-exclusive licensing pacts last month with five generic drugmakers based in India and Pakistan to expand the supply of its Covid-19 treatment.
The drug, which will be marketed under the brand name Covifor, will likely be priced at Rs5,000-6,000 rupees for a 100 milligram dose, Hetero said.
India's Cipla said its generic version of remdesivir will be called Cipremi.
The Drug Controller General of India (DCGI) was not immediately available for comment.
Gilead Sciences Inc signed non-exclusive licensing pacts last month with five generic drugmakers based in India and Pakistan to expand the supply of its Covid-19 treatment.
The pacts allow Jubilant Life Sciences Ltd, Cipla, Hetero Labs, Mylan NV and Ferozsons Laboratories Ltd to make and sell the drug in 127 countries.
Indian drugmaker Zydus Cadila said last week it signed a non-exclusive licensing pact with Gilead Sciences to manufacture and market remdesivir.
More news from
Hospitals brace for uptick in typhoid and bacterial infections; and mosquito- and fly-borne diseases like dengue
With 30% of their inventory damaged, owners of Preloved Books now face the daunting task of rebuilding from scratch
Five-time champions hold their nerve to claim victory by nine runs in the final over at Chandigarh
Natasha Abbas is a British civil engineer who co-founded North 51, a project management consultancy in Dubai
People who are assessing your qualifications can quickly tell the difference between an authentic life narrative and a third-party account
Arab-Canadian public speaking coach and author of The Million Dollar Speaker Maher Elusini on how to make your speech command value for time and money
The legendary Greek-Russian conductor Teodor Currentzis, who is all set to perform at the Dubai Opera next week, on music transcending cultural and language barriers
